STAT+: Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount program
Stat News • 2/26/2026 – 2/27/2026
Summary
The Justice Department is supporting AbbVie in its efforts to overturn a Colorado law. This law prohibits pharmaceutical companies from imposing restrictions on the 340B drug discount program.
Advertisement
Lindy Score Breakdown (V4.2)
13h
Age
1
Sources
from cluster
5
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier93% (0.5^5/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Novo reports ‘triple G’ obesity drug study results
Stat News • 2 days ago
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News • 2 days ago
STAT+: Xenon’s seizure drug study reads out soon. Here’s what to expect
Stat News • Today
STAT+: Pharmalittle: We’re reading about an FDA plan for ultra-rare drugs, Novo cutting GLP-1 drug prices, and more
Stat News • 2 days ago
STAT+: FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad
Stat News • Today
STAT+: GSK picks up pulmonary hypertension drug with 35Pharma acquisition
Stat News • 2 days ago
STAT+: A rare disease drug was approvable, then it wasn’t. Inside a surprise rejection by the FDA
Stat News • 1 day ago
STAT+: Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends
Stat News • 2 days ago
STAT+: FDA rejection is a reality check on agency rhetoric
Stat News • Today
STAT+: The nation’s MAHA mom lands in Congress, with some uncomfortable questions
Stat News • Today